205TiP ATRACTIB: A phase II trial of first-line (1L) atezolizumab (A) in combination with paclitaxel (P) and bevacizumab (B) in metastatic triple-negative breast cancer (mTNBC)

Authors :: A. Cortés Salgado
J.M. Perez Garcia
S.P. Cortez Castedo
M. Gion Cortes
S. Morales Murillo
I. Blancas López-Barajas
S. Blanch
I. Calvo Plaza
N. Diaz Fernandez
F. Marmé
A. Martinez Bueno
M.T. Taberner Bonastre
M. De Laurentiis
M. Ruiz Borrego
P. Schmid
V. Guarneri
J. Gligorov
M. Sampayo-Cordero
A. Llombart Cussac
J. Cortés
Source :: Annals of Oncology. 33:S221
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools